C-kit and its ligand stem cell factor: potential contribution to prostate cancer bone metastasis - Wikidata - wikimedia - TriplyDB

C-kit and its ligand stem cell factor: potential contribution to prostate cancer bone metastasis

C-kit and its ligand stem cell factor: potential contribution to prostate cancer bone metastasis

http://www.wikidata.org/entity/Q36840289

about

Dinosaurs and ancient civilizations: reflections on the treatment of cancer Current Stem Cell Biomarkers and Their Functional Mechanisms in Prostate Cancer Cellular Plasticity in Prostate Cancer Bone Metastasis Cdc6 and cyclin E2 are PTEN-regulated genes associated with human prostate cancer metastasis Neoplasia: the second decade.c-Kit expression, angiogenesis, and grading in canine mast cell tumour: a unique model to study c-Kit driven human malignancies.Possible prognostic and therapeutic significance of c-Kit expression, mast cell count and microvessel density in renal cell carcinoma.Bone-induced c-kit expression in prostate cancer: a driver of intraosseous tumor growth.c-Kit Expression is Rate-Limiting for Stem Cell Factor-Mediated Disease Progression in Adenoid Cystic Carcinoma of the Salivary Glands.Cabozantinib inhibits growth of androgen-sensitive and castration-resistant prostate cancer and affects bone remodeling CD117⁺ cells in the circulation are predictive of advanced prostate cancer The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches Normal peripheral prostate stromal cells stimulate prostate cancer development: roles of c-kit signal Human Stromal Cells in the Peripheral Zone of the Prostate Promote Tumorigenesis of Prostatic Cancer Stem Cells through Up-regulation of C-Kit Expression.Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients.Targeting cells of the myeloid lineage attenuates pain and disease progression in a prostate model of bone cancer Interleukin-1 beta induces the expression and production of stem cell factor by epithelial cells: crucial involvement of the PI-3K/mTOR pathway and HIF-1 transcription complex.A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer.Tie-2 regulates the stemness and metastatic properties of prostate cancer cells.Mast cell regulation of the immune response.CD117 expression in operable oesophageal squamous cell carcinomas predicts worse clinical outcome.The War on Cancer rages on.From pathogenesis to prevention of castration resistant prostate cancer.Pathogenesis of osteoblastic bone metastases from prostate cancer.Targeting tyrosine kinases and autophagy in prostate cancer.The SCF/c-KIT system in the male: Survival strategies in fertility and cancer.Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer.Mir-152 inhibits cell proliferation and colony formation of CD133(+) liver cancer stem cells by targeting KIT.Prognostic role of microRNA-221 in various human malignant neoplasms: a meta-analysis of 20 related studies Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines.Prostate Cancer Stem Cell Markers Drive Progression, Therapeutic Resistance, and Bone Metastasis.Regulation of FGF-2 by an endogenous antisense RNA: effects on cell adhesion and cell-cycle progression.Androgen deprivation and stem cell markers in prostate cancers.Investigation of c-KIT and Ki67 expression in normal, preneoplastic and neoplastic canine prostate.Bone Marrow Microenvironment as a Regulator and Therapeutic Target for Prostate Cancer Bone Metastasis.Mechanisms of receptor tyrosine kinase activation in cancer.CD117/c-kit in Cancer Stem Cell-Mediated Progression and Therapeutic Resistance.Validation of stem cell markers in clinical prostate cancer: α6-integrin is predictive for non-aggressive disease.Contributions of Thyroid Hormone to Cancer Metastasis

P2860

Q24628746-34C99B8C-428E-495D-930E-5DB6528BF105 Q26742062-EE95554D-6D6D-41E9-B2F9-634E69F91C5E Q28085013-99CDD955-9587-43F2-9745-D62F516459F5 Q30440601-F80E76A5-AF36-4A87-8C10-6E4FF6381A74 Q30484000-55A351E4-6749-469F-9762-AD16A1E58FB7 Q33677797-A5935FE0-9CFF-4FAB-A73F-AD57AECAE18D Q34072594-1E0A8EC8-F0FE-4473-BDEB-5871F67A2C74 Q34353130-CC183A0E-820D-43BA-B3D4-F39AEF2E1428 Q34478359-C62F5FF1-EC55-422F-9F62-4848C572702F Q35036800-7E8CE1EC-8F64-4FB8-8087-9E45284A357F Q35176469-21861F0F-82BF-4E8B-8674-4965F55DF005 Q35499809-31A314D7-023B-41FA-AA2C-C9B62588B361 Q35662979-7B040EB6-CC0E-4830-BFAC-52C24DB25EA2 Q35856865-50772FF7-9D94-4118-9114-3DC672FB5E6A Q35956586-5B407D55-8BDA-41DE-AECC-3AE9626B705D Q35985440-63F1E427-6D06-45B1-BF6F-D45DE53D7643 Q36459104-4682C4E6-C8B0-4CFA-9053-135B82743863 Q36462972-C810FA5D-34FA-4227-A312-1BD284B908A6 Q36771868-5D0E73A6-37DB-4FEE-ADE6-E970812F4CD2 Q36834357-E07B1146-8193-46EA-8165-88B036D7C9AC Q37016233-234C7E31-893B-4AAF-A7B9-875FD11F7744 Q37478602-9A4F51AF-C367-485C-8F1A-2B62583D395A Q37598730-BA562BDC-7F59-48BB-8417-8586C6CE1BC2 Q37682761-6853FB41-C8E6-4729-9C41-A784E9A1C261 Q37847052-D7718141-BF7C-4D95-8540-59C3CC86320C Q38264052-2BFD9D92-484D-4C15-BCA7-5DC8242E4BB8 Q38897955-678AE74F-1C37-41C4-B74D-D250C6036BB6 Q38948202-37FD1898-499E-4C7A-BE9E-A7FED984FA3E Q39261238-FE5A99C2-8507-4E66-8089-D4E1243B1C24 Q39410915-4C79EF24-52B4-454C-91E2-3436C7234475 Q39424549-30F2875B-E6EB-4262-ADD3-D97B8DA8A59E Q39644344-595692A6-1C7C-49A0-AF6F-1A048371ECFC Q39744887-BB0B1DB8-A205-4B2E-8749-481CCE871DE0 Q47327428-09BB9E43-A797-4CCF-9B34-D2C1DBB7C780 Q47864550-335DC7C3-AE8E-43A0-8CC9-747E890ACA09 Q49888000-43F3E9CD-E2B3-4DED-8316-FC6ADE3C27B2 Q53703721-9E7E4CEE-D647-46F1-A201-9533A4FDB112 Q54387640-BEB5BF2E-E814-4025-B806-718777FCAB73 Q58717087-B79C0201-9A4D-41BC-8F63-719276320194

P2860

C-kit and its ligand stem cell factor: potential contribution to prostate cancer bone metastasis

http://www.wikidata.org/entity/Q36840289

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

C-kit and its ligand stem cell ...... rostate cancer bone metastasis

@en

type

label

C-kit and its ligand stem cell ...... rostate cancer bone metastasis

@en

prefLabel

C-kit and its ligand stem cell ...... rostate cancer bone metastasis

@en

P1433

Q36840289-B98D09BC-2C79-4AC8-A7AB-E9839B6245C1

P1476

Q36840289-EE3F3CF6-48BB-413F-AA2D-ABFF9A2F445C

P2093

Q36840289-048340D7-CC01-4E96-912A-0FF54C1FF476

Q36840289-0543523F-0170-43E8-96FF-713D3C4029A6

Q36840289-16FBC42A-7D3C-4879-9F15-D0BA8B3DEAB7

Q36840289-215DE643-09BF-4B80-8179-08CC8B7706C6

Q36840289-778C9A5F-86E2-4EF4-9ED5-18BD346F4311

Q36840289-84A0151D-598C-4E0C-8882-81351B0E1047

Q36840289-A945F448-43EC-49EE-A2A2-A28271AB0CB0

Q36840289-AC45329B-EF5E-4222-A42F-6724FA03C958

Q36840289-DA1ADDB0-8604-4322-AA15-56FC44A40E47

Q36840289-DFDC8949-D678-4C80-99B5-00635D3E08A4

P2860

Q36840289-0BD252C4-F2ED-4927-8754-D57A99B9CF57

Q36840289-0CA9625C-F38C-401E-B20E-3E55FE1304D9

Q36840289-1984DFE9-EEB1-4C94-9758-C010859829C9

Q36840289-255C6534-E28B-4AB8-9C1D-28BDCA4DE1A3

Q36840289-3031C726-8953-45DB-86EF-3AD3AF98C772

Q36840289-3A68A9AC-6437-4190-AD1E-0D0FAE6BCC7D

Q36840289-49C1B138-64D8-48FC-A725-9179651A9199

Q36840289-4EC54F98-3A3F-4B62-94B3-0A90083EC069

Q36840289-50E06512-A68F-40EE-86D9-1426016731B1

Q36840289-5836C72B-A026-48BA-9053-07235F05700D

P304

Q36840289-CE67811E-040B-4C68-BD52-DFD2CA16B21D

P31

Q36840289-0A5F72E4-A6EF-45F2-9406-BFF0AC6375BF

P356

Q36840289-0D0261AF-2210-4AFF-AB35-836CD16DF4FD

P433

Q36840289-CEFCDC82-27CF-41EC-B1B7-044B2A07C020

P478

Q36840289-6DF61760-A9C4-4688-B50D-28B30EBD9460

P577

Q36840289-43A59226-5F44-4807-B433-3F3B574D88E1

P5875

Q36840289-B35FFB48-B3AB-44BC-BB03-A4290D089ED3

P698

Q36840289-7D88273D-90FC-4647-9EDE-9BA974409387

P932

Q36840289-99E170CF-0F1B-407B-A1C4-8FCB5F5F00A5

P356

P1433

P1476

C-kit and its ligand stem cell ...... rostate cancer bone metastasis

@en

P2093

Christoph Wiesner

http://www.w3.org/2001/XMLSchema#string

Emanuel Burck Dos Santos

http://www.w3.org/2001/XMLSchema#string

Fernando Bittinger

http://www.w3.org/2001/XMLSchema#string

Hamilto Yamamoto

http://www.w3.org/2001/XMLSchema#string

Hong Meng

http://www.w3.org/2001/XMLSchema#string

Joachim W Thüroff

http://www.w3.org/2001/XMLSchema#string

Michael L Cher

http://www.w3.org/2001/XMLSchema#string

R Daniel Bonfil

http://www.w3.org/2001/XMLSchema#string

Robert L Vessella

http://www.w3.org/2001/XMLSchema#string

Sanaa M Nabha

http://www.w3.org/2001/XMLSchema#string

P2860

Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand

Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2

Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand

Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Chymase cleavage of stem cell factor yields a bioactive, soluble product

Stem cell factor and its receptor c-Kit as targets for inflammatory diseases

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

Receptor tyrosine kinase signalling as a target for cancer intervention strategies

Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant

P304

996-1003

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/NEO.08618

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23181634

http://www.w3.org/2001/XMLSchema#string

P698

18714401

http://www.w3.org/2001/XMLSchema#string

P932

2517645

http://www.w3.org/2001/XMLSchema#string